MECHANISMS OF QUINOLONE RESISTANCE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI HIGHLY RESISTANT TO FLUOROQUINOLONES BUT SUSCEPTIBLE TO NALIDIXIC-ACID

被引:38
作者
MONIOTVILLE, N
GUIBERT, J
MOREAU, N
ACAR, JF
COLLATZ, E
GUTMANN, L
机构
[1] UNIV PARIS 06,MICROBIOL MED LAB,F-75270 PARIS 06,FRANCE
[2] HOP BROUSSAIS,MICROBIOL LAB,F-75674 PARIS 14,FRANCE
[3] CNRS,CTR ETUD & RECH CHIM ORGAN APPL,F-94320 THIAIS,FRANCE
[4] HOP ST JOSEPH,MICROBIOL LAB,F-75674 PARIS 14,FRANCE
关键词
D O I
10.1128/AAC.35.3.519
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Two associated resistance mechanisms were found in a nalidixic acid-susceptible (4-mu-g/ml) but fluoroquinolone-resistant (8 to 16-mu-g/ml) strain of Escherichia coli Q2 selected under norfloxacin therapy. As compared with the susceptible E. coli Q1 isolated before treatment, changes in outer membrane proteins and lipopolysaccharides in Q2 were associated with a 1.5- to 3-fold decrease in the uptake of fluoroquinolones but not nalidixic acid. A 50% inhibition of DNA synthesis in toluene-permeabilized cells of the resistant strain E. coli Q2 required up to 500-fold increased quantities of fluoroquinolones, whereas such inhibition was obtained in both E. coli Q1 and Q2 with similar amounts of nalidixic acid. Selection from E. coli Q1 on norfloxacin of one-step resistant mutants resembling E. coli Q2 was unsuccessful. From these results we infer that a decrease in outer membrane permeability, associated with a peculiar alteration of the DNA gyrase, was responsible for the unusual quinolone resistance phenotype of E. coli Q2.
引用
收藏
页码:519 / 523
页数:5
相关论文
共 21 条
[1]   NORFLOXACIN RESISTANCE IN A CLINICAL ISOLATE OF ESCHERICHIA-COLI [J].
AOYAMA, H ;
SATO, K ;
KATO, T ;
HIRAI, K ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (10) :1640-1641
[2]   INHIBITION OF DNA-REPLICATION INVITRO BY PEFLOXACIN [J].
BADET, B ;
HUGHES, P ;
KOHIYAMA, M ;
FORTERRE, P .
FEBS LETTERS, 1982, 145 (02) :355-359
[3]   ACCUMULATION OF ENOXACIN BY ESCHERICHIA-COLI AND BACILLUS-SUBTILIS [J].
BEDARD, J ;
WONG, S ;
BRYAN, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (09) :1348-1354
[4]   FLUOROMETRIC ASSAY FOR FLEROXACIN UPTAKE BY BACTERIAL-CELLS [J].
CHAPMAN, JS ;
GEORGOPAPADAKOU, NH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :27-29
[5]   ASSOCIATION BETWEEN EARLY INHIBITION OF DNA-SYNTHESIS AND THE MICS AND MBCS OF CARBOXYQUINOLONE ANTIMICROBIAL AGENTS FOR WILD-TYPE AND MUTANT [GYRA NFXB(OMPF) ACRA] ESCHERICHIA-COLI K-12 [J].
CHOW, RT ;
DOUGHERTY, TJ ;
FRAIMOW, HS ;
BELLIN, FY ;
MILLER, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1113-1118
[6]   ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].
COHEN, SP ;
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
MCMURRY, LM ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191
[7]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[8]   ESCHERICHIA COLI K-12 MUTANTS RESISTANT TO NALIDIXIC ACID - GENETIC MAPPING AND DOMINANCE STUDIES [J].
HANE, MW ;
WOOD, TH .
JOURNAL OF BACTERIOLOGY, 1969, 99 (01) :238-&
[9]   MUTATIONS PRODUCING RESISTANCE TO NORFLOXACIN IN PSEUDOMONAS-AERUGINOSA [J].
HIRAI, K ;
SUZUE, S ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (04) :582-586
[10]   DIFFERENCES IN SUSCEPTIBILITY TO QUINOLONES OF OUTER-MEMBRANE MUTANTS OF SALMONELLA-TYPHIMURIUM AND ESCHERICHIA-COLI [J].
HIRAI, K ;
AOYAMA, H ;
IRIKURA, T ;
IYOBE, S ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :535-538